Marc B. Bissonnette

2.5k total citations · 3 hit papers
12 papers, 1.5k citations indexed

About

Marc B. Bissonnette is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Marc B. Bissonnette has authored 12 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Immunology. Recurrent topics in Marc B. Bissonnette's work include RNA modifications and cancer (6 papers), Cancer-related gene regulation (5 papers) and Epigenetics and DNA Methylation (3 papers). Marc B. Bissonnette is often cited by papers focused on RNA modifications and cancer (6 papers), Cancer-related gene regulation (5 papers) and Epigenetics and DNA Methylation (3 papers). Marc B. Bissonnette collaborates with scholars based in United States, China and Taiwan. Marc B. Bissonnette's co-authors include Chuan He, Urszula Dougherty, Renbao Chang, Dali Han, Meng Xu, Chuanyuan Chen, Yi Liu, Bin Shen, Jian‐Ying Wang and Xiaona Huang and has published in prestigious journals such as Nature, Molecular Cell and Nature Immunology.

In The Last Decade

Marc B. Bissonnette

12 papers receiving 1.4k citations

Hit Papers

Anti-tumour immunity controlled through mRNA m6A methylat... 2019 2026 2021 2023 2019 2021 2023 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc B. Bissonnette United States 10 1.3k 656 310 243 110 12 1.5k
Jianning Zhai Hong Kong 10 818 0.7× 435 0.7× 211 0.7× 145 0.6× 87 0.8× 15 1.0k
Arabella Wan China 10 1.1k 0.8× 632 1.0× 133 0.4× 59 0.2× 126 1.1× 18 1.2k
Yunxia Zhou China 9 605 0.5× 497 0.8× 134 0.4× 92 0.4× 36 0.3× 15 841
Liang Shi China 22 906 0.7× 569 0.9× 108 0.3× 37 0.2× 32 0.3× 37 1.1k
Haibiao Xie China 15 723 0.6× 504 0.8× 110 0.4× 68 0.3× 36 0.3× 30 904
Hao Zheng China 19 730 0.6× 605 0.9× 83 0.3× 78 0.3× 10 0.1× 47 1.0k
Song Zhao China 16 459 0.4× 216 0.3× 143 0.5× 96 0.4× 25 0.2× 31 734
Yang Cheng China 13 343 0.3× 194 0.3× 142 0.5× 144 0.6× 14 0.1× 25 621
Yongqian Shu China 16 658 0.5× 347 0.5× 135 0.4× 43 0.2× 33 0.3× 22 773
Jiang Shi China 14 619 0.5× 446 0.7× 75 0.2× 50 0.2× 21 0.2× 25 753

Countries citing papers authored by Marc B. Bissonnette

Since Specialization
Citations

This map shows the geographic impact of Marc B. Bissonnette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc B. Bissonnette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc B. Bissonnette more than expected).

Fields of papers citing papers by Marc B. Bissonnette

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc B. Bissonnette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc B. Bissonnette. The network helps show where Marc B. Bissonnette may publish in the future.

Co-authorship network of co-authors of Marc B. Bissonnette

This figure shows the co-authorship network connecting the top 25 collaborators of Marc B. Bissonnette. A scholar is included among the top collaborators of Marc B. Bissonnette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc B. Bissonnette. Marc B. Bissonnette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Ma, Shoubao, Baofa Sun, Songqi Duan, et al.. (2023). YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8+ T cells. Nature Immunology. 24(2). 255–266. 143 indexed citations breakdown →
2.
Zhang, Rukang, Dong Chen, Hao Fan, et al.. (2022). Cellular signals converge at the NOX2-SHP-2 axis to induce reductive carboxylation in cancer cells. Cell chemical biology. 29(7). 1200–1208.e6. 4 indexed citations
3.
Gao, Xue, Yijie Liu, Yuancheng Li, et al.. (2022). Lyso-PAF, a biologically inactive phospholipid, contributes to RAF1 activation. Molecular Cell. 82(11). 1992–2005.e9. 10 indexed citations
4.
Chen, Chuanyuan, Yawei Zhang, Zhenghang Wang, et al.. (2021). The loss of RNA N6-adenosine methyltransferase Mettl14 in tumor-associated macrophages promotes CD8+ T cell dysfunction and tumor growth. Cancer Cell. 39(7). 945–957.e10. 201 indexed citations breakdown →
5.
Sun, Hui‐Lung, Allen Zhu, Yawei Gao, et al.. (2020). Stabilization of ERK-Phosphorylated METTL3 by USP5 Increases m6A Methylation. Molecular Cell. 80(4). 633–647.e7. 143 indexed citations
6.
Han, Dali, Jun Liu, Chuanyuan Chen, et al.. (2019). Author Correction: Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells. Nature. 568(7751). E3–E3. 22 indexed citations
7.
Han, Dali, Jun Liu, Chuanyuan Chen, et al.. (2019). Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells. Nature. 566(7743). 270–274. 737 indexed citations breakdown →
8.
Sehdev, Amikar, Theodore Karrison, Yuanyuan Zha, et al.. (2018). A pharmacodynamic study of sirolimus and metformin in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 82(2). 309–317. 14 indexed citations
9.
Chapman, Christopher G., Christopher J. Mariani, Feng Wu, et al.. (2015). TET-catalyzed 5-hydroxymethylcytosine regulates gene expression in differentiating colonocytes and colon cancer. Scientific Reports. 5(1). 17568–17568. 43 indexed citations
10.
Sehdev, Amikar, Ya‐Chen Tina Shih, B. G. Vekhter, et al.. (2014). Metformin for primary colorectal cancer prevention in patients with diabetes: A case‐control study in a US population. Cancer. 121(7). 1071–1078. 77 indexed citations
11.
Wang, Chong-Zhi, Karen Kim, Lian‐Wen Qi, et al.. (2011). Ultra-Performance Liquid Chromatography and Time-of-Flight Mass Spectrometry Analysis of Ginsenoside Metabolites in Human Plasma. The American Journal of Chinese Medicine. 39(6). 1161–1171. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026